Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


Toddlers Now Get Benefits Of Probiotics

MEDIA RELEASE

For immediate release

July 23, 2014

Toddlers Now Get Benefits Of Probiotics

Dunedin-based BLIS Technologies has launched a new probiotic powder suitable for children as young as six months old. The powder, part of the BLIS K12™ product range, is aimed at introducing healthy bacteria into the mouth and throats of young children to support ear, nose and throat health.

CEO Barry Richarson says every parent dreads the onset of middle ear infection in their child.

“Some children are lucky and seldom get middle ear infections. Others, though, are prone to them. And like most childhood illnesses, they’re worse at night. Chances are high that all children will have at least one middle ear infection before they turn six.”

Middle ear infection often begins with a sore throat or cold. Many middle ear infections are viral and don’t respond to antibiotics. Pain relief and time to recover are as much as as any parent can do. For bacterial caused middle ear infections treatment can be ineffective if started too late and the result is likely to be a burst eardrum, and hearing loss for the duration of the infection.

University of Otago researcher Professor John Tagg discovered BLIS K12™, the world’s first bacterial replacement probiotic specifically developed for both the mouth and the throat. It was isolated after Professor Tagg noticed some children didn’t get sore throats as often as others. Analysing their saliva, he found those children having fewer (or no) sore throats had different types of bacteria in their saliva.

BLIS K12™ is a probiotic that has been shown in trials1-3 to reduce the frequency of throat infections and middle ear infections.

“When taken regularly it maintains the healthy bacterial population in the saliva to a level that staves off infections. And that’s a win-win. Healthier children means less time off work for working parents,” says Richardson.

Italian clinical trials of BLIS K12™ in children who regularly came down with streptococcal sore throats, the source of middle ear infection, showed over 90% reduction in doctor visits, days off school and, as a result, days off work for parents looking after sick children3.

The group of treated children spent a combined total of 30 days under antibiotic treatment while the control group spent a combined total of 900 days on antibiotics.

Traditionally, BLIS K12™ only came in lozenge form.

“That’s an effective way for older children and adults to take the supplement, but it doesn’t work for tots. So now it’s available in a strawberry and vanilla flavoured powder sprinkled over food twice a day.”

Pilot studies1 of children with recurrent ear infections indicate that children taking BLIS K12™ had 67% fewer ear infection recurrences compared to a control group.

New Zealand studies4,5 also show the healthy BLIS K12™ bacteria can transfer to the nasopharynx – the upper part of the throat behind the nose – which is the bacterial reservoir for ear infections.

Bacterial sore throats can lead to more serious complications such as rheumatic fever. Rheumatic heart disease is largely unknown in developed countries, but causes 160 deaths in New Zealand each year, a rate that is even higher than that observed in third world nations.

ENDS

List of citations:

1: Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media. Int J Gen Med. 2012;5:991-7

2: Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults. Expert Opin Biol Ther. 2013 Mar;13(3):339-43.

3: Use of Streptococcus salivarius K12 in the prevetion of streptococcal and viral pharynotonsillitis in children. Drug Health Patient Safety. 2014:Feb 13: 6: 15-20

4: BLIS Technologies. Internal report

5: Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12. Eur J Clin Microbiol Infect Dis. 2008 Jun 17.


© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

BusinessDesk: APN's NZME Sees Future In Paywalls, Growth In Digital Sales

APN News & Media has touted a single newsroom concept for its NZME unit in New Zealand, similar to what Germany's Die Welt uses, saying an 'integrated sales proposition' is helping it win market share, including ... More>>

Labour Party: Global Milk Prices Now Lowest In 6 Years

The latest fall in the global dairy price has brought it to the lowest level in six years and shows there must be meaningful action in tomorrow’s Budget to diversify the economy, says Labour’s Finance spokesperson Grant Robertson. “Dairy prices ... More>>

BusinessDesk: NZ Inflation Expectations Creep Higher In June Survey

May 19 (BusinessDesk) - New Zealand businesses lifted their expectations for inflation over the next two years, sapping any immediate pressure on the Reserve Bank to cut interest rates, and prompting the kiwi dollar to jump higher. More>>

BusinessDesk: Lower Fuel Costs Drive Down NZ Producer Input, Output Prices

May 19 - Producer input and output prices fell in the first quarter, mainly reflecting lower fuel costs and weakness in prices of meat and dairy products. More>>

Media: Fairfax Media NZ Announces Senior Editorial Team

Fairfax Media New Zealand has today confirmed its new editorial leadership team, as part of a transformation of its newsrooms aimed at enhancing local and national journalism across digital and print. More>>

Science: Flavonoids Reduce Cold And Cough Risk

Flavonoids reduce cold and cough risk Research from the University of Auckland shows eating flavonoids – found in green tea, apples, blueberries, cocoa, red wine and onions – can significantly reduce the risk of catching colds and coughs. The research, ... More>>


BusinessDesk: RBNZ House Alert Speech The Catalyst For Government Action

Prime Minister John Key all but conceded that pressure from the Reserve Bank of New Zealand for concerted action on rampant Auckland house prices was one of the main catalysts for the government's weekend announcements about tightly ... More>>

BusinessDesk: How To Fall Foul Of The New Housing Tax Rules: Tips From IRD

Just because you rented out your investment property doesn't absolve you from paying tax, says the Inland Revenue Department in a summary of commonly made mistakes by non-professional property investors when it comes to their tax liability.More>>

Legal: Superdiversity Law, Policy And Business Stocktake Announced

Mai Chen, Managing Partner at Chen Palmer New Zealand Public and Employment Law Specialists and Adjunct Professor of Law at the University of Auckland, today announced the establishment ... More>>

Housing: More House Price Gains Expected

House price expectations remain high, with a net 56% of respondents expecting house prices will increase. Fears of higher interest rates are fading, consistent with the RBNZ’s signals this year. Affordability and a lack of houses for ... More>>

TDDA: State-Of-The-Art Drug Testing Laboratory To Open In Auckland

World leading drug testing agencies, The Drug Detection Agency (TDDA) and Omega Laboratories, open New Zealand laboratory More>>

Network: Bigpipe Launches Ultra-Fast Broadband Into Wellington

Bigpipe Launches Ultra-Fast Broadband into Wellington Naked broadband provider Bigpipe has extended its national reach, announcing today, the launch of its unlimited UFB offering into Wellington. The Spark Venture business is giving Wellingtonians the ... More>>

Get More From Scoop

 
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news